tiprankstipranks
Trending News
More News >
Biotest AG (GB:0N70)
LSE:0N70
UK Market

Biotest (0N70) Income Statement

Compare
0 Followers

Biotest Income Statement

Last quarter (Q4 2024), Biotest's total revenue was €203.50M, an increase of 10.42% from the same quarter last year. In Q4, Biotest's net income was €-3.50M. See Biotest’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 726.20M€ 684.60M€ 516.10M€ 515.60M€ 484.20M
Gross Profit
€ 223.80M€ 280.30M€ 124.90M€ 80.70M€ 130.10M
Operating Expenses
€ 129.30M€ 136.80M€ 133.40M€ 132.80M€ 132.60M
Depreciation and Amortization
€ 40.60M€ 35.90M€ 35.70M€ 31.10M€ 29.60M
EBITDA
€ 120.40M€ 179.00M€ 28.30M€ -17.70M€ 16.00M
Operating Income
€ 94.50M€ 143.50M€ -13.00M€ -52.10M€ -13.20M
Other Income/Expenses
€ -48.00M€ -37.20M€ -17.90M€ -15.60M€ -16.80M
Pretax Income
€ 46.50M€ 106.30M€ -30.80M€ -62.60M€ -30.00M
Net Income
€ 26.40M€ 127.00M€ -31.60M€ -63.30M€ -31.40M
Per Share Metrics
Basic EPS
€ 0.71€ 3.21€ -0.80€ -1.60€ -0.79
Diluted EPS
€ 0.71€ 3.21€ -0.80€ -1.60€ -0.79
Weighted Average Shares Outstanding
39.57M 39.57M 39.57M 39.57M 39.57M
Weighted Average Shares Outstanding (Diluted)
39.57M 39.57M 39.57M 39.57M 39.57M
Currency in EUR

Biotest Earnings and Revenue History